A randomized, controlled, double-blind, pilot study of milk thistle for the treatment of hepatotoxicity in childhood acute lymphoblastic leukemia (ALL) (2010)

Peer-Reviewed Study · Ladas EJ, Kroll DJ, Oberlies NH, Cheng B, Ndao DH, Rheingold SR, Kelly KM · January 15, 2010

Ladas EJ et al., 2010-01-15: Double-blind randomised pilot trial in 50 children with ALL and chemotherapy-related hepatotoxicity: milk thistle produced no significant change in liver enzymes at day 28, the primary time point, and lower AST at day 56.

There were no significant changes in mean amino alanine transferase (ALT), aspartate amino transferase (AST), or total bilirubin (TB) at Day 28.

Abstract, Results

Ladas EJ et al., 2010-01-15: Double-blind randomised pilot trial in 50 children with ALL and chemotherapy-related hepatotoxicity: milk thistle produced no significant change in liver enzymes at day 28, the primary time point, and lower AST at day 56. Study type: randomized trial.